Cellectis logo

Cellectis

CLLS | NASDAQ
Chart Builder DCF Calculator
$1.04
-$0.14 (-11.86%)
At close: Nov 16, 2026, 4:00 PM ET
$1.04
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-11.86%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
38.5
-1.5 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #562/1021 (Top 55%)

Key Statistics

Market Data

Market Cap $104.76M
1D Range
1.00 1.14
52W Range
0.93 5.35

Valuation (TTM)

PE -1.58
PB 2.55
EV/EBITDA -0.41

Valuation (NTM)

Forward PE N/A
Forward PEG -0.03
Price Target $2.15
Loading financial charts...

Profile

Cellectis S.A. is a biotechnology firm in the clinical development stage, concentrating on the creation of immuno-oncology therapies. These therapies harness gene-edited T-cells engineered to express ...

Sector Healthcare
Industry Biotechnology
Employees 229
IPO Date Mar 24, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.61
Miss -238.89%
REV
$3.76M
Miss -75.89%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Hold
Price Target
$2.15
Upside
+106.73%
Buy (1)
Hold (2)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.